Dhanuka Laboratories Profile
Key Indicators
- Authorised Capital ₹ 14.50 Cr
- Paid Up Capital ₹ 13.85 Cr
- Company Age 31 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 153.10 Cr
- Satisfied Charges ₹ 1,018.28 Cr
About Dhanuka Laboratories
Dhanuka Laboratories Limited (DLL) is a leading Public Limited Indian Non-Government Company incorporated in India on 24 February 1993 and has a history of 31 years and 11 months. Its registered office is in Chennai, Tamil Nadu, India.
The Corporate was formerly known as Dhanuka Laboratories Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 14.50 Cr and a paid-up capital of Rs 13.85 Cr.
The company currently has active open charges totaling ₹153.10 Cr. The company has closed loans amounting to ₹1,018.28 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Dhanuka Laboratories Limited India are Preeti as COMPANY SECRETARY and Pramod Singh as Cfo. Sanjay Bagaria, Urmila Dhanuka, Kunj Sonthalia, and Six other members serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24100TN1993PLC149053
- Company No.
052285
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
24 Feb 1993
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
What products or services does Dhanuka Laboratories Limited offer?
Dhanuka Laboratories Limited offers a wide range of products and services, including Cereals & Food Grains, Sugar, Herbicides, Cotton, Fungicides, Plant Growth Regulators, Biofit Stim Rich, Insecticides, Fresh Vegetables, Potato.
Who are the key members and board of directors at Dhanuka Laboratories?
Executive Team (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Preeti | Company Secretary | 05-Apr-2024 | Current |
Pramod Singh | CFO | 23-Aug-2023 | Current |
Manish Dhanuka ![]() | Managing Director | 24-Feb-1993 | Current |
Board Members (8)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Seema Dhanuka ![]() | Director | 21-Sep-1996 | Current |
Sanjay Bagaria ![]() | Director | 16-Nov-2018 | Current |
Rahul Dhanuka ![]() | Director | 02-Mar-1999 | Current |
Mridul Dhanuka ![]() | Director | 06-Oct-2005 | Current |
Urmila Dhanuka ![]() | Director | 24-Oct-2001 | Current |
Kunj Sonthalia ![]() | Director | 25-Feb-2015 | Current |
Financial Performance of Dhanuka Laboratories.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Dhanuka Laboratories?
Unlock access to Dhanuka Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Charges (Loans)
₹153.10 Cr
₹1,018.28 Cr
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 85.00 Cr
- Hdfc Bank Limited : 30.10 Cr
- Yes Bank Limited : 18.00 Cr
- Others : 10.00 Cr
- The Hongkong And Shanghai Banking Corporation Limited : 10.00 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
29 Jul 2022 | Hdfc Bank Limited | ₹1.00 M | Open |
29 Dec 2020 | Others | ₹10.00 Cr | Open |
12 Jun 2020 | Axis Bank Limited | ₹85.00 Cr | Open |
14 Jan 2016 | The Hongkong And Shanghai Banking Corporation Limited | ₹10.00 Cr | Open |
20 Dec 2011 | Yes Bank Limited | ₹18.00 Cr | Open |
How Many Employees Work at Dhanuka Laboratories?
Unlock and access historical data on people associated with Dhanuka Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Dhanuka Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dhanuka Laboratories's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.